Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
12,439 total articles
AMD commits 2 billion over five years to accelerate AI innovation, advance research, and expand national AI infrastructure in the United Kingdom through strategic partnerships with top universities and initiatives focused on next-generation computing technology.
Alvotech announced that the U.S. FDA has accepted its Biologics License Application for AVT16, an interchangeable biosimilar candidate to Entyvio® (vedolizumab). Developed in partnership with Teva Pharmaceutical, AVT16 targets treatment of ulcerative colitis and Crohn’s disease. The acceptance signifies progress toward potentially expanding patient…
Willis Towers Watson (WTW) announces the expansion of its international property facility, now providing up to $60 million follow capacity per placement supported by the Neuron algorithmic digital platform. The facility covers diverse regions including Europe, Asia, and Canada, and targets multiple sectors such as airports, leisure, industrial, inf…
onsemi introduced the Elite Pairing Studio, an online interactive simulation tool that simplifies and accelerates the pairing of SiC MOSFETs and gate drivers for power electronics applications. The tool allows engineers to evaluate device-level behaviors and trade-offs early in the design process, enhancing efficiency and reducing development cycle…
Ingredion Incorporated (NYSE: INGR) has announced a recommended all-cash acquisition of Tate & Lyle PLC, a global leader in specialty ingredients, in a transaction valued at approximately $5.0 billion. The acquisition will combine complementary ingredient portfolios and geographic supply networks, enhancing Ingredion’s specialty ingredients platfor…
Rackspace Technology has established a regional headquarters in Riyadh, Saudi Arabia, to strengthen its presence in the Middle East and to accelerate cloud adoption and AI-driven digital transformation consistent with Saudi Arabia's Vision 2030. The new hub aims to support enterprises, government, and regulated sectors across the Gulf Cooperation C…
Nurix Therapeutics has announced a global collaboration with Roche to co-develop and co-commercialize bexobrutideg, a promising oral BTK degrader drug candidate. The deal includes a $700 million upfront payment to Nurix with potential milestones totaling up to $2.3 billion. The partnership aims to advance clinical development in malignant hematolog…
WISeKey International Holding Ltd, along with The Hashgraph Group and Hedera, has launched the QAIT Q-Day Security Assessment Platform within the SEALCOIN Quantum Marketplace. This pioneering service enables organizations to assess and prepare for cybersecurity risks introduced by advancing quantum computing, combining AI, blockchain, and post-quan…
Digital Realty (NYSE: DLR), the world's largest cloud- and carrier-neutral data center platform, has launched its operations in Malaysia, marking a significant milestone in its Southeast Asia expansion. The company plans to develop approximately 32 MW of data center capacity in Cyberjaya across three interconnected facilities, designed to support A…
Rumble Inc. announced the successful completion of its exchange offer to acquire Northern Data AG, securing approximately 85% of outstanding shares. The transaction is expected to close mid-June 2026, leading to the delisting of Northern Data from the Munich stock exchange. This acquisition aims to create a leading independent AI computation, cloud…
Solidion Technology Inc. announced a $35 million private placement of common stock priced above market under Nasdaq rules, fully funding the company through 2028. The proceeds will accelerate commercialization of its patented Extreme-Climate Battery technology targeting the lunar economy, space applications, AI data centers, electric vehicles, and …
LENZ Therapeutics announces that Everest Medicines has acquired the rights from Corxel Pharmaceuticals to develop, manufacture, and commercialize VIZZ® (LNZ100) in Greater China. This strategic move positions LENZ to benefit from up to $85 million in regulatory and sales milestones plus royalties, as the first FDA-approved aceclidine-based eye drop…
Odysight.ai has established an At-The-Market (ATM) program authorizing the company to sell up to $20 million in common stock through Roth Capital Partners. This strategic move aims to provide the company with flexible financing options to support ongoing business development and capitalize on market opportunities without obligating immediate share …
SK Telecom announced plans to build a large-scale AI Cloud in Korea based on NVIDIA's DSX platform, with the first AI factory expected online in 2027. This infrastructure aims to support AI workloads for enterprises and industries across Korea, leveraging SK Telecom's network and data center expertise alongside NVIDIA's accelerated computing and so…
NVIDIA and SK hynix announce a strategic multiyear technology partnership focused on co-developing advanced memory solutions for next-generation AI infrastructure, including AI supercomputers, CPUs, and robotics platforms. The collaboration also includes applying AI to semiconductor chip design, manufacturing, and autonomous factory operations thro…
GoHealth, Inc., a Medicare-focused digital health insurance marketplace, has voluntarily filed for Chapter 11 bankruptcy with unanimous lender support to implement a restructuring plan. The plan transitions ownership to lenders, reinstates preferred equity, assures full payment of trade obligations, intends to maintain uninterrupted business operat…
Senseonics Holdings, Inc. reported new real-world data at the American Diabetes Association Scientific Sessions showcasing the strong performance and patient adherence of its Eversense 365 implantable continuous glucose monitoring (CGM) system. The data from over 12,000 sensors confirm sustained accuracy and positive glycemic outcomes over a full y…
All In FutureTech Alliance (Nasdaq: AIFA) provided a strategic update on accelerating its transformation into an AI infrastructure platform leveraging optical technologies. Key developments include expanding the Hainan AIFA Silicon Photonics Supercomputing Center project into a broader Digital Industrial Park, progressing in governmental approvals …
Cullinan Therapeutics reported initial Phase 1 clinical data for CLN-978, a CD19xCD3 T cell engager, showing clinical benefit including remissions in patients with refractory systemic lupus erythematosus (SLE) and difficult-to-treat rheumatoid arthritis (RA). Data demonstrated deep, dose-dependent B cell depletion in blood and tissue along with a f…
InterPrivate Investment Partners V, Inc., a blank check company focused on mergers and acquisitions, has closed its initial public offering of 20,125,000 units at $10 per unit, raising $201.25 million before expenses. The units began trading on Nasdaq under the ticker symbol IPVVU, with plans to list their Class A shares and warrants separately in …
Bluejay Diagnostics has closed an $8.5 million private placement priced at-the-market on Nasdaq, with potential to raise an additional $15.2 million through warrant exercises. The proceeds are expected to extend the company's cash runway into Q1 2027, supporting FDA submission and subsequent commercialization of its near-patient sepsis testing prod…
MannKind Corporation announced new clinical and real-world data on Afrezza, its inhaled insulin product, at the ADA 2026 Scientific Sessions. The data build on the recent FDA approval for pediatric use and highlight Afrezza’s safety, efficacy, and patient treatment satisfaction in children, adolescents, and gestational diabetes patients. Additional…
Kailera Therapeutics and Hengrui Pharma announced encouraging clinical results for ribupatide, a GLP-1/GIP dual agonist, in both oral and injectable forms for obesity treatment. Phase 2 data from Hengrui showed up to 12.1% mean weight loss with the oral pill over 26 weeks with favorable tolerability. Kailera's Phase 1 trial of the injection demonst…
Biomea Fusion presented promising clinical and translational data for its oral menin inhibitor icovamenib at the ADA 86th Scientific Sessions, demonstrating benefits in type 1 and type 2 diabetes including improved insulin secretion, glycemic control, muscle preservation, and fat reduction. Additionally, the company announced expansion of its Phase…
B2Gold Corp., an international gold producer, reported the results of its 2026 Annual General and Special Meeting held on June 4, 2026. Shareholders voted overwhelmingly in favor of all business items, including the election of ten directors, appointment of PricewaterhouseCoopers LLP as auditor, approval of the Restricted Share Unit Plan, and advis…
